Skip to content

Affera Integrated Mapping System

by Medtronic, Inc. 2 variants

510(k) K243892

Affera Integrated Mapping System is a Class II device made by Medtronic, Inc., cleared under FDA 510(k) K243892 on 17 Jan 2025, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK243892 Date17 Jan 2025ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
DQK
Device class
Class II
Regulation
21 CFR Part 870.1425
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Devices cleared under K243892

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K243892
UDI-DISize and differences
Affera™ Integrated Mapping System AFR-00016
MEDTRONIC, INC.
AFR-0001600763000998271 —On the market

Similar devices

Other devices filed under FDA product code DQK (Computer, Diagnostic, Programmable).

Other devices from Medtronic, Inc.

See all devices from Medtronic, Inc. →